Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-04 LAMATTINA JOHN L Director Option exercise · Non-Qualified Stock Option (right to buy) −4,000 3,335
2018-05-15 HIGGINS JOHN L Chief Executive Officer Option exercise +12,405 $16.14 $200K 119,824
2018-05-15 HIGGINS JOHN L Chief Executive Officer Sale −12,405 $179.97 $2.2M 107,419
2018-05-15 HIGGINS JOHN L Chief Executive Officer Option exercise · Incentive Stock Option (right to buy) −12,405 29,790
2018-05-10 FOEHR MATTHEW W President and COO Option exercise +8,881 $14.47 $129K 110,082
2018-05-10 FOEHR MATTHEW W President and COO Sale −8,881 $167.63 $1.5M 101,201
2018-05-10 FOEHR MATTHEW W President and COO Option exercise +1,055 $9.97 $11K 102,256
2018-05-10 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −1,055 41,026
2018-05-10 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −8,881 45,675
2018-04-02 KOZARICH JOHN W Director Sale −2,500 $160.43 $401K 30,649
2018-03-12 Sabba Stephen L Director Sale −622 $180.73 $112K 26,363
2018-03-09 Aryeh Jason Director Sale −4,000 $176.47 $706K 79,334
2018-03-08 Aryeh Jason Director Sale −3,500 $174.88 $612K 83,334
2018-03-06 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +1,136 27,975
2018-03-06 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −392 $165.87 $65K 27,583
2018-03-06 HIGGINS JOHN L Chief Executive Officer Grant or award +6,015 110,401
2018-03-06 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −2,982 $165.87 $495K 107,419
2018-03-06 FOEHR MATTHEW W President and COO Grant or award +2,940 102,658
2018-03-06 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,457 $165.87 $242K 101,201
2018-03-06 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +2,004 14,765

Page 52 of 55 · 1,097 trades